Effect of antimicrobial therapy on progression free survival of immunotherapy and chemo-/ immunotherapy in patients with NSCLC.

被引：0
|
作者：
Uhlenbruch, M. [1 ]
Krueger, S. [1 ]
机构：
[1] Florence Nightingale Krankenhaus Dusseldorf, Klin Pneumol Kardiol Internist Intensivmed, Dusseldorf, Germany
来源：
PNEUMOLOGIE | 2024年 / 78卷
关键词：
D O I：
10.1055/s-0044-1778946
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV 27
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [31] Association of Sarcopenia with Survival in Advanced NSCLC Patients Receiving Concurrent Immunotherapy and Chemotherapy
    Bolte, F. J.
    McTavish, S.
    Wakefield, N.
    Shantzer, L.
    Hubbard, C.
    Krishnaraj, A.
    Novicoff, W.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S353 - S353
  • [32] Serum Proteomic Signature as a Potential Biomarker for Survival in Patients with NSCLC Receiving Immunotherapy
    Kim, W. B.
    Viveiros, P.
    Anker, J.
    Simon, N.
    Rhee, K.
    Song, J.
    Cho, A.
    Chang, S.
    Ko, T.
    Oh, M.
    Davis, A.
    Park, L. C.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S793 - S794
  • [33] Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy
    Bolte, Fabian J. J.
    McTavish, Sloane
    Wakefield, Nathan
    Shantzer, Lindsey
    Hubbard, Caroline
    Krishnaraj, Arun
    Novicoff, Wendy
    Gentzler, Ryan D. D.
    Hall, Richard D. D.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Effect of prehydration on progression free survival in NSCLC patients treated with low dose chemoradiation
    Rossi, M. M. G.
    Uijterlinde, W. I.
    Smeekens, M.
    Chen, C.
    Belderbos, J. S. A.
    Sonke, J. J.
    van den Heuvel, M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S640 - S640
  • [35] The Impact of Tumor Molecular Features and Smoking History on Survival with Chemo-Immunotherapy in EGFR-Mutant NSCLC
    Bodor, J. N.
    Zhou, Y.
    Cheung, M.
    Borghaei, H.
    Clapper, M. L.
    Treat, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S254 - S254
  • [36] Immunotherapy effect on survival of acute myeloid leukemia patients
    Shi, Runhua
    Li, Teena
    Shi, Lawrence
    Mills, Glenn
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [37] Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease
    Taarnhoj, Gry A.
    Johansen, Christoffer
    Lindberg, Henriette
    Basch, Ethan
    Dueck, Amylou
    Pappot, Helle
    CANCER MEDICINE, 2020, 9 (09): : 3078 - 3087
  • [38] Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy
    Griffiths, Robert
    Gleeson, Michelle
    Reyes, Carolina
    Knopf, Kevin
    Danese, Mark
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (12) : 963 - 967
  • [39] Early detection of disease progression in NSCLC patients undergoing immunotherapy through ctDNA analysis
    Calvo de Juan, V.
    Robado de Lope, L.
    Collazo Lorduy, A.
    Blanco Clemente, M.
    Pena Cabia, S.
    Sequero Lopez, S.
    Massuti Sureda, B.
    Diz Tain, P.
    Vazquez Estevez, S.
    Mielgo Rubio, X.
    Oramas Rodriguez, J. M.
    Sala Gonzalez, M. A.
    Lopez Martin, A.
    Rogado, J.
    Sanchez Hernandez, A.
    Coves Sarto, J.
    Gonzalez-Larriba, J. L.
    Martinez De Castro, A. M.
    Romero, A.
    Provencio Pulla, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S864 - S865
  • [40] Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy
    Fox, Thomas A.
    Troy-Barnes, Ethan
    Kirkwood, Amy A.
    Chan, Wei Yee
    Day, James W.
    Chavda, Selina J.
    Kumar, Emil A.
    David, Kate
    Tomkins, Oliver
    Sanchez, Emilie
    Scully, Marie
    Khwaja, Asim
    Lambert, Jonathan
    Singer, Mervyn
    Roddie, Claire
    Morris, Emma C.
    Yong, Kwee L.
    Thomson, Kirsty J.
    Ardeshna, Kirit M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (02) : 194 - 206
12345